Healthcare -
Biotechnology - NASDAQ - US
$ 19.6
1.34 %
$ 3.27 B
Market Cap
14.41
P/E
ACAD - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ACAD - ACADIA Pharmaceuticals Inc.
32 M
LAST VALUE
56.53%
2 YEAR CAGR
19.60%
5 YEAR CAGR
8.47%
10 YEAR CAGR